Cargando…

Optimization of AAV vectors to target persistent viral reservoirs

Gene delivery of antiviral therapeutics to anatomical sites where viruses accumulate and persist is a promising approach for the next generation of antiviral therapies. Recombinant adeno-associated viruses (AAV) are one of the leading vectors for gene therapy applications that deliver gene-editing e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colón-Thillet, Rossana, Jerome, Keith R., Stone, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067653/ https://www.ncbi.nlm.nih.gov/pubmed/33892762 http://dx.doi.org/10.1186/s12985-021-01555-7

Ejemplares similares

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
por: Skorput, Alexander G. J., et al.
Publicado: (2022)

Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir
por: Roychoudhury, Pavitra, et al.
Publicado: (2018)

AAV1 is the optimal viral vector for optogenetic experiments in pigeons (Columba livia)
por: Rook, Noemi, et al.
Publicado: (2021)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Monocytes and Macrophages as Viral Targets and Reservoirs
por: Nikitina, Ekaterina, et al.
Publicado: (2018)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle
por: Pacak, Christina A, et al.
Publicado: (2008)

Transcriptional Targeting Approaches in Cardiac Gene Transfer Using AAV Vectors
por: Schröder, Lena C., et al.
Publicado: (2023)

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
por: Srivastava, Arun
Publicado: (2023)

Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain
por: Stone, Daniel, et al.
Publicado: (2023)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Tailoring the AAV2 capsid vector for bone-targeting
por: Alméciga-Díaz, Carlos J., et al.
Publicado: (2018)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
por: Eichhoff, Anna Marei, et al.
Publicado: (2019)

The Reservoir of Persistent Human Papillomavirus Infection; Strategies for Elimination Using Anti-Viral Therapies
por: Zheng, Ke, et al.
Publicado: (2022)

Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line
por: Stiefelhagen, Marius, et al.
Publicado: (2008)

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2022)

Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays
por: Buck, Thilo M., et al.
Publicado: (2020)

Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies
por: Colón-Thillet, Rossana, et al.
Publicado: (2023)

Specificity and off-target effects of AAV8-TBG viral vectors for the manipulation of hepatocellular gene expression in mice
por: Kiourtis, Christos, et al.
Publicado: (2021)

Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters
por: Nieuwenhuis, Bart, et al.
Publicado: (2023)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer
por: Konkalmatt, Prasad R., et al.
Publicado: (2013)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2023)

Goody two plasmids: An optimized transient transfection system for AAV vector production
por: Moreno Velasquez, Sergio David, et al.
Publicado: (2023)

Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model
por: Campbell, Elena S. B., et al.
Publicado: (2023)

Microglia-specific targeting by novel capsid-modified AAV6 vectors
por: Rosario, Awilda M, et al.
Publicado: (2016)

AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
por: Weber, Nicholas D., et al.
Publicado: (2014)

Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
por: Kim, Hwijin, et al.
Publicado: (2006)

AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
por: Hartmann, Jessica, et al.
Publicado: (2019)

Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
por: Prakoso, Darnel, et al.
Publicado: (2021)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives
por: Hanaford, Allison R., et al.
Publicado: (2022)

Intra-tracheal delivery of AAV6 vectors results in sustained transduction in murine lungs without genomic integration
por: Colon-Cortes, Yanerys, et al.
Publicado: (2020)

Optimized pharmacological control over the AAV-Gene-Switch vector for regulable gene therapy
por: Cheng, Shi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j1vdffqetg4lc0dcoqdbm2a8h4